Biopharmaceutical Contamination Control
Aseptic Processing Solution
Professional Wiping System for GMP Clean Environments,From R&D to Production, Providing Compliant, Safe, and Efficient Cleaning Validation Solutions for the Pharmaceutical Industry
5/5
bupclean
One-stop industry service
15 years experience
Biopharmaceutical Industry Solutions
| Application | Recommended Product | Specifications | Sterilization | Packaging |
|---|---|---|---|---|
| Aseptic Filling Line | Sterile BN.11040324 | 233.93% Abs., Sterile | Gamma Irradiation | 10 pcs/pack, 10 packs/case |
| Lyophilizer Chamber | Sterile BN.11051103 | Composite, High Abs. | Gamma Irradiation | 5 pcs/pack, 20 packs/case |
| Isolator Interior | Sterile BN.11050135 | Low Residue, NVR<3μg/cm² | Gamma Irradiation | 20 pcs/pack, 10 packs/case |
| Critical Surfaces | Sterile BN.11040218 | General Purpose, 254% Abs. | Gamma Irradiation | 25 pcs/pack, 8 packs/case |
Clean Production Areas (Grade C/D)
Compounding Area: BN.11050207, Cost-effective, 178.31% Abs.
Formulation Area: BN.11050202, Mid-performance, 185.91% Abs.
Packaging Area: BN.11050137, Durable Type, 162.08% Abs.
Equipment Exteriors: BN.11050312, Heavy-duty Cleaning, 158.71% Abs.
Quality Control Areas
Balance Room: BN.11040324, Ultra-low particle, reduces static interference.
HPLC Room: BN.11050135, Low chemical residue, prevents cross-contamination.
Microbiology Lab: BN.11040218, Easy to sterilize, prevents bioburden.
Physicochemical Lab: BN.11050201, General cleaning, economical.
Company Partners
Reliable Guarantee Customer case feedback
4.9/5
Dr. Rachel Haldims
Solving a 5nm wafer defect problem
Surface charge decreased from 250V to <50V, and defect rate decreased from 12% to 1.8%.
5/5
Dr. Mariel Senry
Static electricity damage and lint can cause short circuits.
The electrostatic discharge (ESD) failure rate decreased from 8% to 0.6%, and the short circuit rate decreased from 5% to 0.3%.
4.8/5
Dr. Damian Pix
Optical equipment lens maintenance
No new scratches, charge maintained at <30V for over 8 hours, and imaging resolution improved by 15%.
4.5/5
Dr. Shi Yon
Wafer surface particulate contamination
The surface particulate contamination rate of wafers decreased by 70%, and the overall yield increased by 5%.
Biopharmaceutical Solutions–Ensuring Sterility and Compliance from Drug Substance to Fill-Finish
Proper biopharmaceutical contamination control plays a vital role in modern drug manufacturing. We design our solutions for aseptic processing, cell therapy, gene therapy, and large‑molecule production. Our cleaning materials, disinfectants, and single‑use systems support every step from bioreactor harvesting to final fill‑finish. We manufacture all products inside ISO Class 5 environments. Furthermore, we test each batch thoroughly for particle shedding, extractables, and biocidal effectiveness. Consequently, our customers achieve high yields and maintain patient safety across monoclonal antibodies, vaccines, and ATMPs.
How do your cleanroom wipers meet strict particle and fiber release requirements for aseptic filling areas?
We engineer our wipers specifically for Grade A (ISO Class 5) environments. A continuous filament, 100% polyester microfiber construction with laser‑sealed edges eliminates virtually all particle and fiber shedding. We validate every batch according to IEST‑RP‑CC004.3. For example, particle release (≥0.5 µm) measures ≤5 particles per square foot, and no visible fibers appear under magnification. Additionally, these wipers work well with common sporicidal agents and 70% IPA, and they keep their structural integrity without delamination. Therefore, operators widely choose them for cleaning RABS, isolators, and filling needle assemblies during aseptic processing.
We struggle with residue and incompatibility when using disinfectants on critical surfaces. How does your product address these issues?
We offer a family of pre‑saturated wipers and sterile disinfectant solutions. Our formulations (quaternary ammonium, bleach alternative, and peracetic acid) leave very low nonvolatile residue (below 10 mg/m²). We also test them on common cleanroom surfaces such as 316L stainless steel, polycarbonate, and epoxy floors, where they show excellent compatibility. The pre‑wetted wipers maintain precise saturation levels, so operator variability drops significantly. For sterile processing, we supply gamma‑irradiated, double‑bagged products that achieve a sterility assurance level of 10⁻⁶. Moreover, we provide a full certificate of analysis for each batch, including residual moisture and endotoxin testing.
Can you customize your solutions for specific bioprocess steps like viral vector production or high‑potency drug handling?
Yes, we offer extensive customization. First, we produce custom formats such as die‑cut wipers, continuous rolls, and sterile sleeve systems to fit filling machine wipers, port cleaning tools, and transfer ports. Second, we develop specialized materials for high‑potency API handling. For example, our adsorbent wipers (cross‑linked polyethylene or activated carbon nonwoven) safely capture trace powders and thus reduce operator exposure. Third, we provide validation support, including custom spiking studies with a surrogate virus or protein, extractables profiling for contact surfaces, and microbial growth promotion testing. Finally, we engineer single‑use bioprocess cleaning tools to order. These include pre‑sterilized, lot‑traceable wipers and sleeves that work seamlessly with single‑use bioreactor ports and chromatography skids.
What is your quality assurance process, and can you support our audit and qualification requirements?
- Raw Material Control: Incoming fiber certification.
- In-process Checks: SPC (Statistical Process Control) on knitting, sewing, and cleaning.
- Final Batch Testing: Each batch is sampled and tested for particles, NVR, and ESD in our in-house lab. We provide full Certificate of Analysis (CoA) and Compliance (CoC).
We fully support customer audits (virtual or on-site) and provide all necessary documentation for your supplier qualification portal.